BackVertex Pharmaceuticals Overview

Vertex Pharmaceuticals Long-Term Investments

Track Vertex Pharmaceuticals's long-term investments ($5.8B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long-Term Investments
$5.79B
↑ 2.54% YoYΔ $143.20M vs prior year quarter

Peer trimmed avg / median

Loading

Vertex Pharmaceuticals Long-Term Investments History

Loading

Vertex Pharmaceuticals vs. peers: Long-Term Investments Comparison

Loading

Vertex Pharmaceuticals Long-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vertex Pharmaceuticals (VRTX) FAQ

As of the most recent data (June 2026), VRTX shows a long-term investments of $5.8B. That compares with $5.6B in the prior-year period — up 2.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VRTX's long-term investments is now $5.8B (was $5.6B) — a 2.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Vertex Pharmaceuticals is outperforming or lagging.

Tracking VRTX's long-term investments over time shows whether Vertex Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $5.8B That compares with $5.6B in the prior-year period — up 2.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term investments page, Stockcircle has Vertex Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term investments (currently $5.8B) with ownership activity and broader fundamentals.

Vertex Pharmaceuticals's long-term investments is $5.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.